Carcinogenicity prediction by in vitro human liver cell gene expression and chemical structure
暂无分享,去创建一个
Zhen Tian | Lixin Liu | Chengcai Lv | Yushi Liu | Karin Yanagi | Z. Tian | Karin Yanagi | Yushi Liu | Lixin Liu | Chengcai Lv
[1] J. Chang,et al. Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer , 2011, Oncogene.
[2] Yoshihiro Yamanishi,et al. Extracting Sets of Chemical Substructures and Protein Domains Governing Drug-Target Interactions , 2011, J. Chem. Inf. Model..
[3] Urs A. Meyer,et al. Overview of enzymes of drug metabolism , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[4] K. D. Sørensen,et al. The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer , 2012, International journal of cancer.
[5] C. Gespach,et al. Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. , 2000, Biochemical and biophysical research communications.
[6] R. Dammann,et al. Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma , 2015, Front. Endocrinol..
[7] Vladimir B Bajic,et al. In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.
[8] Ting Chen,et al. Global optimization-based inference of chemogenomic features from drug-target interactions , 2015, Bioinform..
[9] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[10] H. Bonkovsky,et al. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration , 2000, American Journal of Gastroenterology.
[11] J. Ptak,et al. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers , 2006, Human mutation.
[12] Jürgen Bajorath,et al. Design of chemical space networks using a Tanimoto similarity variant based upon maximum common substructures , 2015, Journal of Computer-Aided Molecular Design.
[13] Daniel C. Liebler,et al. Elucidating mechanisms of drug-induced toxicity , 2005, Nature Reviews Drug Discovery.
[14] Li Shang,et al. Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells , 2015, Oncotarget.
[15] Andrey A Toropov,et al. CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] J. Gustafsson,et al. Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression , 2009, Breast Cancer Research.
[17] Ian Spence,et al. Combining machine learning models of in vitro and in vivo bioassays improves rat carcinogenicity prediction , 2018, Regulatory toxicology and pharmacology : RTP.
[18] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[19] N. Kaplowitz,et al. Mechanisms of drug-induced liver injury. , 2013, Clinics in liver disease.
[20] Jie Li,et al. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug–target interactions and drug repositioning , 2016, Briefings Bioinform..
[21] R. Uzzo,et al. A global profile of gene promoter methylation in treatment-naïve urothelial cancer , 2014, Epigenetics.
[22] Ö. Türeci,et al. Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE). , 2015, Lung cancer.
[23] T. Sasahira,et al. NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma , 2016, Virchows Archiv.
[24] Yu Shyr,et al. Effects of cancer-associated EPHA3 mutations on lung cancer. , 2012, Journal of the National Cancer Institute.
[25] D. Amacher,et al. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. , 2010, Toxicology and applied pharmacology.
[26] G. Ilia,et al. Potential carcinogenicity predicted by computational toxicity evaluation of thiophosphate pesticides using QSTR/QSCarciAR model , 2017, Drug and chemical toxicology.
[27] Lara E Sucheston-Campbell,et al. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] C. Dang,et al. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.
[29] Alexander E. Kel,et al. Identification of Differentially Expressed Genes by Meta-Analysis of Microarray Data on Breast Cancer , 2008, Silico Biol..
[30] Cheng Peng,et al. Novel naïve Bayes classification models for predicting the carcinogenicity of chemicals. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[31] N. Kosaka,et al. Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment. , 2013, Advanced drug delivery reviews.
[32] H. Yamada,et al. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database. , 2011, Toxicology and applied pharmacology.
[33] D. Kanduc,et al. Genome‐wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor‐associated signatures , 2006, The Journal of dermatology.
[34] Joseph S. Verducci,et al. A Modification of the Jaccard–Tanimoto Similarity Index for Diverse Selection of Chemical Compounds Using Binary Strings , 2002, Technometrics.
[35] M. Urioste,et al. MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma , 2012, Clinical Cancer Research.
[36] H. Ellinger-Ziegelbauer,et al. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. , 2008, Mutation research.
[37] Darko Butina,et al. Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets , 1999, J. Chem. Inf. Comput. Sci..
[38] P. Brousset,et al. RNA editing in acute myeloid leukaemia with normal karyotype , 2016, British journal of haematology.
[39] C. Wongkham,et al. Roles and Mechanisms of β-Thymosins in Cell Migration and Cancer Metastasis: An Update , 2013, Cancer investigation.
[40] K. Pacak,et al. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC‐associated factor X , 2014, International journal of cancer.
[41] D A Smith,et al. Role of reactive metabolites in drug-induced hepatotoxicity. , 2010, Handbook of experimental pharmacology.
[42] Hua Yu,et al. Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.
[43] M. Tessier-Lavigne,et al. Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor , 2014, PloS one.
[44] I. Bièche,et al. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. , 1994, Cancer research.
[45] Hiroshi Yamada,et al. Open TG-GATEs: a large-scale toxicogenomics database , 2014, Nucleic Acids Res..
[46] R. Povinelli,et al. Novel Uses of In Vitro Data to Develop Quantitative Biological Activity Relationship Models for in Vivo Carcinogenicity Prediction , 2015, Molecular informatics.
[47] N. Hynes,et al. Key signalling nodes in mammary gland development and cancer: Myc , 2009, Breast Cancer Research.
[48] Long Yu,et al. Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. , 2002, Gene expression.
[49] C. David Page,et al. Human pluripotent stem cell-derived neural constructs for predicting neural toxicity , 2015, Proceedings of the National Academy of Sciences.
[50] B. Crosas. Deubiquitinating enzyme inhibitors and their potential in cancer therapy. , 2014, Current cancer drug targets.
[51] Jian Zhao,et al. CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods , 2017, Scientific Reports.
[52] Peng Chen,et al. MicroRNA-1254 exerts oncogenic effects by directly targeting RASSF9 in human breast cancer. , 2018, International journal of oncology.
[53] M. Ellis,et al. TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. , 2018, Cancer research.
[54] M. Gariboldi,et al. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer , 2011, Breast Cancer Research and Treatment.
[55] Aixia Yan,et al. Carcinogenicity prediction of noncongeneric chemicals by a support vector machine. , 2013, Chemical research in toxicology.
[56] Vladimir Poroikov,et al. ROSC-Pred: web-service for rodent organ-specific carcinogenicity prediction , 2018, Bioinform..
[57] N. Kaplowitz,et al. Drug-Induced Liver Disorders , 2001, Drug safety.
[58] P. Lemotte,et al. TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. , 2012, Cancer cell.
[59] Zengrui Wu,et al. In Silico Estimation of Chemical Carcinogenicity with Binary and Ternary Classification Methods , 2015, Molecular informatics.
[60] Payam Shahi,et al. microRNA-mediated regulation of the tumor microenvironment , 2013, Cell cycle.
[61] Jürgen Bajorath,et al. Erratum to: Design of chemical space networks using a Tanimoto similarity variant based upon maximum common substructures , 2015, Journal of Computer-Aided Molecular Design.
[62] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[63] Bo Yin,et al. Incremental Learning Based on Probabilistic SVM and SVDD and Its Application to Acoustic Signal Recognition , 2017, 2017 International Conference on Sensing, Diagnostics, Prognostics, and Control (SDPC).
[64] F. Colland,et al. Ubiquitin-specific proteases as cancer drug targets. , 2011, Future oncology.
[65] A. Bode,et al. USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer , 2013, Clinical Cancer Research.
[66] M. Cantile,et al. Homeobox genes and cancer. , 1999, Experimental cell research.
[67] Dario Strbenac,et al. Regional activation of the cancer genome by long-range epigenetic remodeling. , 2013, Cancer cell.
[68] William M. Lee. Acute Liver Failure in the United States , 2003, Annals of Internal Medicine.
[69] Joshua A. Bittker,et al. The Carcinogenome Project: In-vitro Gene Expression Profiling of Chemical Perturbations to Predict Long-Term Carcinogenicity , 2018, bioRxiv.
[70] A. Nicolas,et al. Germline mutation in the RAD51B gene confers predisposition to breast cancer , 2013, BMC Cancer.